MPWT
KNSA icon

MassMutual Private Wealth & Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$224 Buy
+3
New +$221 ﹤0.01% 2326

Other funds holding KNSA

TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
CCAL
City Center Advisors LLC Troy, Michigan $131M AUM 24.02% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

MassMutual Private Wealth & Trust's KNSA Position: Q3 2026 in Review

MassMutual Private Wealth & Trust opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 3 shares worth $224. The stake represents ﹤0.01% of the portfolio and ranks #2326 among its holdings.

8 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • MassMutual Private Wealth & Trust held 3 shares of Kiniksa Pharmaceuticals worth $224 as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new MassMutual Private Wealth & Trust position in Q3 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #2326 holding.
  • 8 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.